[HTML][HTML] Small airway inflammation and extrafine inhaled corticosteroids plus long-acting beta2-agonists formulations in chronic obstructive pulmonary disease
P Pirina, MPF Barbaro, D Paleari, A Spanevello - Respiratory Medicine, 2018 - Elsevier
Objectives To summarize the evidence of small airways involvement in chronic obstructive
pulmonary disease (COPD) pathophysiology, and to evaluate the efficacy of extrafine …
pulmonary disease (COPD) pathophysiology, and to evaluate the efficacy of extrafine …
Inhaled corticosteroid use in chronic obstructive pulmonary disease and risk of pneumonia: a nested case-control population-based study in Lazio (Italy)—The …
S Cascini, U Kirchmayer, V Belleudi… - COPD: Journal of …, 2017 - Taylor & Francis
Inhaled corticosteroid (ICS) use in chronic obstructive pulmonary disease (COPD) patients is
associated with a reduction of exacerbations and a potential risk of pneumonia. The …
associated with a reduction of exacerbations and a potential risk of pneumonia. The …
Хроническая обструктивная болезнь легких: индикаторы качества, алгоритм диагностики и терапии
ИВ Лещенко, СН Авдеев - РМЖ, 2016 - elibrary.ru
В Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD 2016) особое
внимание обращено на уменьшение клинической симптоматики, улучшение качества …
внимание обращено на уменьшение клинической симптоматики, улучшение качества …
Role of Tiotropium in Reducing Exacerbations of Chronic Obstructive Pulmonary Disease When Combined With Long‐Acting β2‐Agonists and Inhaled …
E Ferroni, V Belleudi, S Cascini… - The Journal of …, 2016 - Wiley Online Library
Combined inhaled therapy in chronic obstructive pulmonary disease (COPD) is commonly
used, but its benefits remain controversial. We assessed the effect of tiotropium in reducing …
used, but its benefits remain controversial. We assessed the effect of tiotropium in reducing …
One‐year mortality associated with COPD treatment: a comparison of tiotropium and long‐acting beta2‐agonists in three Italian regions: results from the OUTPUL …
U Kirchmayer, S Cascini, N Agabiti… - … and drug safety, 2016 - Wiley Online Library
Purpose Long‐acting bronchodilators, ie beta‐2‐agonists (LABA) and tiotropium are
commonly used in COPD treatment. Choice of a specific agent is based on effectiveness …
commonly used in COPD treatment. Choice of a specific agent is based on effectiveness …
[PDF][PDF] a SySTemaTiC revieW of CaSe-idenTifiCaTion algoriTHmS baSed on iTalian HealTHCare adminiSTraTive daTabaSeS for TWo relevanT diSeaSeS of THe …
WHT iS already KnoWn - Epidemiol Prev, 2019 - researchgate.net
ConClUSion: elements from the review on the use of healthcare administrative databases
represent a useful tool to decide which algorithm to adopt, based on the algorithm's …
represent a useful tool to decide which algorithm to adopt, based on the algorithm's …
Observational studies in COPD: summary of guidance for authors
Observational studies have played an important role in identifying risk factors associated
with chronic obstructive pulmonary disease (COPD), as well as its natural history, and …
with chronic obstructive pulmonary disease (COPD), as well as its natural history, and …
O papel dos corticosteroides inalados no tratamento da DPOC estável
FMF Barbosa - 2020 - estudogeral.uc.pt
A doença pulmonar obstrutiva crónica (DPOC) é uma doença inflamatória
crónicacaracterizada por sintomas respiratórios e limitação do fluxo aéreo não reversível …
crónicacaracterizada por sintomas respiratórios e limitação do fluxo aéreo não reversível …
[PDF][PDF] Особенности клинического течения и тактики ведения коморбидного больного с хронической обструктивной болезнью легких и хронической сердечной …
АИ Халецкая - 2018 - kazangmu.ru
Хроническая обструктивная болезнь легких (ХОБЛ) в последние десятилетия
приобретает большую актуальность во всех странах мира в связи с повсеместным …
приобретает большую актуальность во всех странах мира в связи с повсеместным …
Trattamento personalizzato dei pazienti con BPCO in fase stabile
G Caramori, P Casolari, M Carone… - … di Patologia dell' …, 2016 - aiporassegna.it
Nella pratica clinica non esiste più alcuna giustificazione per un nichilismo terapeutico in
quanto oggi il trattamento personalizzato farmacologico e non farmacologico dei pazienti …
quanto oggi il trattamento personalizzato farmacologico e non farmacologico dei pazienti …